Use of smoking cessation pharmacotherapies during pregnancy is not associated with increased risk of adverse pregnancy outcomes: a population-based cohort study

BACKGROUND: Varenicline, bupropion and nicotine replacement therapy (NRT) are three effective pharmacotherapies for smoking cessation, but data about their safety in pregnancy are limited. We assessed the risk of adverse perinatal outcomes and major congenital anomalies associated with the use of th...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:BMC Med
Main Authors: Tran, Duong Thuy, Preen, David B., Einarsdottir, Kristjana, Kemp-Casey, Anna, Randall, Deborah, Jorm, Louisa R., Choi, Stephanie K. Y., Havard, Alys
Formato: Artigo
Idioma:Inglês
Publicado em: BioMed Central 2020
Assuntos:
Research Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC7001233/
https://ncbi.nlm.nih.gov/pubmed/32019533
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12916-019-1472-9
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados